The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD

V. Molotov-Luchanskiy, L. Muravluyova, D. Kluyev (Karaganda, Kazakhstan)

Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session: Translational studies in chronic lung diseases: from bedside to bench
Session type: Poster Discussion
Number: 257
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Molotov-Luchanskiy, L. Muravluyova, D. Kluyev (Karaganda, Kazakhstan). The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD. Eur Respir J 2013; 42: Suppl. 57, 257

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015


The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014

Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015

Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015

Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013


Redox systems of neutrophils of patients with exacerbated COPD
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008

TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014

Methylated arginine derivatives can differ stable and unstable patients with COPD
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013



Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013

Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014

Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015